Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer

Eric Van Cutsem, Malcolm J. Moore, Jean‐Luc Van Laethem et al.|Journal of Clinical Oncology|2009

Cited by 643